Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Microbiotix Co., Ltd

Clinical trials sponsored by Microbiotix Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Virus cocktail targets superbug pneumonia in first human test Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Virus cocktail targets superbug pneumonia in first human test

Disease control Recruiting now

This early-stage trial tests MP101, a mix of two viruses that attack bacteria (phages), in 18 adults with Pseudomonas aeruginosa pneumonia. Participants receive a single dose of MP101 or a placebo alongside standard antibiotics. The main goal is to check safety and how the body h…

Phase 1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC